Arcutis Biotherapeutics (NASDAQ:ARQT) is a biopharmaceutical company focused on developing innovative treatments for patients dealing with dermatological diseases. The company has dedicated its research and development efforts to creating highly differentiated therapies to improve the lives of those burdened by skin conditions. Its portfolio boasts projects aimed at tackling prevalent issues such as psoriasis, atopic dermatitis, and other skin diseases with significant unmet needs. Arcutis's objectives center around leveraging its expertise in dermatology to bring forward new, effective treatments that can offer both safety and efficacy, providing relief and improved quality of life for patients. With a deep commitment to science and patient care, Arcutis Biotherapeutics aims to leave a lasting impact on the field of dermatology by addressing and fulfilling the needs of a diverse patient population.